M. A. Soylemez, "DIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN," DIABETES TECHNOLOGY & THERAPEUTICS , vol.17, 2015
Soylemez, M. A. 2015. DIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN. DIABETES TECHNOLOGY & THERAPEUTICS , vol.17 .
Soylemez, M. A., (2015). DIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN. DIABETES TECHNOLOGY & THERAPEUTICS , vol.17.
Soylemez, MEHMET. "DIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN," DIABETES TECHNOLOGY & THERAPEUTICS , vol.17, 2015
Soylemez, MEHMET A. . "DIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN." DIABETES TECHNOLOGY & THERAPEUTICS , vol.17, 2015
Soylemez, M. A. (2015) . "DIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN." DIABETES TECHNOLOGY & THERAPEUTICS , vol.17.
@article{article, author={MEHMET ALİ SÖYLEMEZ}, title={DIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN}, journal={DIABETES TECHNOLOGY & THERAPEUTICS}, year=2015}